drugset / Trial / NCT07577999

The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy

NCT07577999

Phase 0 Not yet recruiting 20 enrolled Stanford University
NaSingle-groupOpen-labelSupportive care

Summary

This will be an open-label, single group supportive care pilot study in which patients are given cannabinoid gummies in the perioperative setting to alleviate RC/UD symptoms and improve quality of life. The primary objective will be to evaluate the safety and tolerability of a cannabigerol supplement used perioperatively (from 14 days prior to surgery to 30 days following surgery) by patients undergoing radical cystectomy with urinary diversion (RC/UD).

Timeline

Start
2027-07
Primary completion
2028-05
Completion
2028-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabigerol Small molecule 6.25 mg Oral
Subject Cannabigerol Small molecule 12.5 mg Oral
Subject Cannabigerol Small molecule 25 mg Oral